MiNK Therapeutics (INKT) Stock Chart & Stock Price History $12.06 -0.60 (-4.74%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$11.92 -0.14 (-1.13%) As of 08/8/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock MiNK Therapeutics Stock Price Performance The MiNK Therapeutics (INKT) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 52.66%, with a year-to-date return of 73.05%. In the past month, the stock has increased 56.02%, reflecting recent market activity. As of the latest close, MiNK Therapeutics traded at $12.06 with a market cap of $48.07 million and volume of 175,191 shares. Receive INKT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for MiNK Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-17.00%1 Month Performance+56.02%3 Month Performance+71.55%Year-To-Date Performance+73.05%1 Year Performance+52.66% INKT Stock Chart for Sunday, August, 10, 2025 INKT Chart by TradingView MiNK Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/08/2025$12.66$12.06-4.74%$12.89$11.60175,191 shs$48.07 million08/07/2025$13.06$12.66-3.06%$13.33$12.30122,001 shs$50.51 million08/06/2025$14.53$13.06-10.12%$14.67$12.78127,747 shs$52.11 million08/05/2025$13.22$14.53+9.91%$14.90$12.69113,223 shs$57.98 million08/04/2025$14.72$13.22-10.19%$15.21$13.22313,590 shs$52.75 million08/01/2025$15.16$14.72-2.90%$16.05$14.3682,979 shs$60.42 million07/31/2025$16.54$15.16-8.34%$16.94$15.08169,503 shs$60.49 million07/30/2025$16.70$16.54-0.96%$17.68$16.40134,516 shs$66.00 million07/29/2025$18.71$16.70-10.74%$19.07$16.02155,481 shs$66.57 million07/28/2025$18.56$18.71+0.81%$19.61$18.38332,690 shs$74.65 million Get the Latest News and Ratings for INKT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for MiNK Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 07/25/2025$19.00$18.56-2.32%$20.25$18.56124,778 shs$74.05 million07/24/2025$20.06$19.00-5.28%$20.00$18.54138,952 shs$75.81 million07/23/2025$21.05$20.06-4.70%$21.50$19.40182,237 shs$79.96 million07/22/2025$19.80$21.05+6.31%$21.45$19.72211,609 shs$83.99 million07/21/2025$20.31$19.80-2.51%$22.34$18.67517,532 shs$79.00 million07/18/2025$23.25$20.31-12.65%$24.00$20.14677,478 shs$81.04 million07/17/2025$23.11$23.25+0.61%$30.30$23.201.86 million shs$92.67 million07/16/2025$28.01$23.11-17.49%$30.64$23.11877,142 shs$92.21 million07/15/2025$40.61$28.01-31.03%$34.50$27.521.47 million shs$111.65 million07/14/2025$64.17$40.61-36.71%$52.50$33.625.03 million shs$161.87 million07/11/2025$7.73$64.17+730.14%$76.00$20.2047.69 million shs$255.78 million07/10/2025$7.63$7.73+1.38%$7.80$7.522,666 shs$30.84 million07/09/2025$7.20$7.63+5.90%$7.88$7.282,822 shs$30.42 million Related Companies enGene Stock Chart GENFIT Stock Chart Eupraxia Pharmaceuticals Stock Chart C4 Therapeutics Stock Chart Innate Pharma Stock Chart Puma Biotechnology Stock Chart China SXT Pharmaceuticals Stock Chart Instil Bio Stock Chart Journey Medical Stock Chart Cybin Stock Chart Receive INKT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for MiNK Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:INKT) was last updated on 8/10/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | Sponsored"Death Spiral" Threatening Your SavingsThe "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredIs This Stock the 'Next Nvidia'?'AI Bottleneck' Now Threatens Entire Magnificent 7 A new critical failure has appeared in the AI market, an...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MiNK Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MiNK Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
